Histologic analysis reveals MSC therapy activates TRAIL, suggesting a potential strategy for lung cancer brain metastasis treatment.
Histologic and molecular analyses of therapeutic outcomes in the brain metastasis model. A, Histologic examination of brain tumor tissues stained with hematoxylin and eosin (H&E) and Ki67. B, Quantification of tumor lesion area in the brain. C, Representative images of Ki67 immunostaining in brain tumor lesions. D, Quantification of Ki67-positive cells per group. E–H, Immunofluorescence staining for cleaved caspase-3 and CD31 in brain tissues, visualized using the ScanScope AT system (Leica Biosystems). Immunofluorescence staining for cleaved caspase-3 and CD31 in brain tissues, visualized using the ScanScope AT system (Leica Biosystems). E and F, Representative images and quantification of cleaved caspase-3–positive cells. G and H, Representative images and quantification of CD31-positive cells. Data are presented as the mean ± SD; n = 5 per group. P values of statistical significance are represented as *, P < 0.05; **, P < 0.001; and ***, P < 0.0001. DAPI, 4′,6-diamidino-2-phenylindole, dihydrochloride.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: